Visionary Leadership
A rare convergence of clinical medicine and cutting-edge technology, this professional brings an MBBS foundation (Gold Medal) elevated by a PGDSML in Data Science & Machine Learning from IIT Guwahati — positioning them at the precise intersection where healthcare’s deepest problems meet AI’s most powerful solutions.
With expertise spanning ICH-GCP, HIPAA, clinical trials, NLP, LLMs, Deep Learning, RWE, Big Data Analytics, and platforms including Medidata, Veeva, and Epic — this is a professional who does not choose between being a clinician, a scientist, or a technologist. They are all three, simultaneously, and at scale.
At the core of their work is a singular belief: that medicine, transformed by intelligent systems, can operate at a scale and precision previously unimaginable.
Their flagship contribution — the HAPI (Healthcare API) platform — stands as testament to this vision. By architecting and standardizing an NER, NLP, and AI/ML-integrated system subsequently adopted across multiple international clinical research platforms, they demonstrated that one well-built solution can reshape entire research ecosystems globally.
Their Guideline-Directed Medical Therapy (GDMT) algorithms translate the most rigorous clinical evidence into optimized, real-world workflows — bridging the persistent and costly gap between what medicine knows and what practitioners do. Similarly, their Gene NER Standardization initiative brought structured intelligence to the chaotic landscape of global genomic research databases, enabling scalable, cross-institutional scientific collaboration.
On the regulatory frontier, their contributions to FDA-approved ECG and early detection algorithms represent the highest-stakes validation a technology can receive in healthcare — proof that their AI work doesn’t merely theorize but saves lives within regulatory reality.
Recognized with the Bravo Edison Award for Healthcare API quality excellence, published in the Journal of Clinical Oncology, and presented at ASCO 2024 (Chicago) on deep learning applications in metastatic breast cancer, their work operates simultaneously at clinical, academic, and technological summits.
Their influence extends across the global pharma and healthcare landscape — having partnered on high-priority AI-driven research with Pfizer, Janssen, BMS, Merck, Novartis, Takeda, Thermo Fisher, and GE Healthcare, while working within major hospital systems including Mayo Clinic, Duke Health, Banner Health, and Mercy Hospitals. They have also trained 20+ physicians in AI-powered clinical research — multiplying their impact by building human capacity at the frontline of medicine.
